Sinha Vikas
Chief Financial Officer at SRRK; Director at VRNA; Officer, Director, 10% owner at ALVR, and 1 more
- Sold, on record
- $82.2M
- Dollars the filings state
- Form 4 sales
- 99
- Latest Apr 16, 2026
- Form 144 notices
- 11
- Proposed sales
- Companies
- 4
- Filed as an executive or holder
Companies
- SRRKScholar Rock Holding CorpChief Financial Officer
- VRNAVerona Pharma plcDirector
- ALVRAllovir, Inc.Officer, Director, 10% owner
- ALEXION PHARMACEUTICALS INCEVP & CFO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ALEXION PHARMACEUTICALS INC708,731 shares
- VRNA204,568 shares
- ALVR106,402 shares
- SRRK27,165 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ALVRNo planJan 10 2025
Sold 979 shares at $0.44 ($431)
Sinha Vikas, Officer, Director, 10% owner
No 10b5-1 planSold 0.1% of holdings ($502k position)1.1M shares left0.3x usual sizeFiling
- 2 Form 4 sale ALVRNo planJan 23 +13 days
Sold 129 shares at $9.50 ($1k)
Sinha Vikas, Officer, Director, 10% owner
No 10b5-1 planSold 0.3% of holdings ($471k position)49,432 shares left0x usual sizeFiling
- 3 Form 4 sale ALVRNo planFeb 21 +29 days
Sold 303 shares at $10.08 ($3k)
Sinha Vikas, Officer, Director, 10% owner
No 10b5-1 planSold 0.6% of holdings ($498k position)49,129 shares left0.1x usual sizeFiling
- 4 Form 4 sale VRNARoutineApr 29 +67 days
Sold 20,000 shares at $8.92 ($178k)
Sinha Vikas, Director
10b5-1 planSold 21.2% of holdings ($842k position)74,440 shares leftFirst sale on recordFiling
- 5 Form 4 sale VRNARoutineMay 20 +21 days
Sold 160,000 shares at $9.39 ($1.5M)
Sinha Vikas, Director
10b5-1 planSold 68.2% of holdings ($2.2M position)74,440 shares leftFiling
- 6 Form 4 sale VRNANo planAug 1 +73 days
Sold 4,328 shares at $13.14 ($57k)
Sinha Vikas, Director
No 10b5-1 planSold 4.4% of holdings ($1.3M position)94,112 shares leftFiling
- 7 Form 4 sale SRRKNo planJan 13 +165 days
Sold 16,755 shares at $42.70 ($715k)
Sinha Vikas, Chief Financial Officer
No 10b5-1 planSold 2.8% of holdings ($25.6M position)583,245 shares leftFirst sale on recordFiling
- 8 Form 4 sale SRRKNo planApr 16 +93 days
Sold 10,410 shares at $49.57 ($516k)
Sinha Vikas, Chief Financial Officer
No 10b5-1 planSold 1.7% of holdings ($31.2M position)619,856 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (110)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Apr 16, 2026 | SRRK | Chief Financial Officer | Form 4 sale | 10,410 | $516k | 1.7% | No plan | SEC |
| Jan 13, 2026 | SRRK | Chief Financial Officer | Form 4 sale | 16,755 | $715k | 2.8% | No plan | SEC |
| Aug 1, 2025 | VRNA | Director | Form 4 sale | 4,328 | $57k | 4.4% | No plan | SEC |
| May 20, 2025 | VRNA | Director | Form 4 sale | 160,000 | $1.5M | 68.2% | Routine | SEC |
| Apr 29, 2025 | VRNA | Director | Form 4 sale | 20,000 | $178k | 21.2% | Routine | SEC |
| Feb 21, 2025 | ALVR | Officer, Director, 10% owner | Form 4 sale | 303 | $3k | 0.6% | No plan | SEC |
| Jan 23, 2025 | ALVR | Officer, Director, 10% owner | Form 4 sale | 129 | $1k | 0.3% | No plan | SEC |
| Jan 10, 2025 | ALVR | Officer, Director, 10% owner | Form 4 sale | 979 | $431 | 0.1% | No plan | SEC |
| Nov 19, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 3,186 | $2k | 0.3% | No plan | SEC |
| Nov 5, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 5,136 | $4k | 0.4% | No plan | SEC |
| Oct 22, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 3,428 | $3k | 0.3% | No plan | SEC |
| Oct 3, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 940 | $761 | 0.1% | No plan | SEC |
| Aug 19, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 3,159 | $2k | 0.3% | No plan | SEC |
| Aug 5, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 5,251 | $4k | 0.5% | No plan | SEC |
| Jul 22, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 3,400 | $3k | 0.3% | No plan | SEC |
| Jul 2, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 939 | $676 | 0.1% | No plan | SEC |
| May 17, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 3,143 | $2k | 0.3% | No plan | SEC |
| May 3, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 4,957 | $4k | 0.4% | No plan | SEC |
| Apr 22, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 3,378 | $3k | 0.3% | No plan | SEC |
| Apr 2, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 885 | $681 | 0.1% | No plan | SEC |
| Feb 20, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 2,893 | $2k | 0.3% | No plan | SEC |
| Feb 5, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 18,331 | $12k | 1.6% | Unusual | SEC |
| Jan 23, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 3,205 | $2k | 0.3% | No plan | SEC |
| Jan 4, 2024 | ALVR | Officer, Director, 10% owner | Form 4 sale | 961 | $615 | 0.1% | No plan | SEC |
| Jan 4, 2024 | ALVR | Owner, Officer, Director | Form 144 notice | 961 | $614 | Notice | SEC | |
| Nov 17, 2023 | ALVR | Officer, Director, 10% owner | Form 4 sale | 2,490 | $4k | 0.2% | Routine | SEC |
| Nov 17, 2023 | ALVR | Officer, Director, 10% Stockholder | Form 144 notice | 2,490 | $4k | Notice | SEC | |
| Oct 20, 2023 | ALVR | Officer, Director, 10% owner | Form 4 sale | 2,707 | $4k | 0.2% | Routine | SEC |
| Oct 20, 2023 | ALVR | Officer, Director, 10% Stockholder | Form 144 notice | 1,475 | $2k | Notice | SEC | |
| Oct 19, 2023 | ALVR | Officer, Director, 10% Stockholder | Form 144 notice | 1,232 | $2k | Notice | SEC | |
| Oct 3, 2023 | ALVR | Officer, Director, 10% owner | Form 4 sale | 755 | $1k | 0.1% | Routine | SEC |
| Oct 3, 2023 | ALVR | Officer, Director, 10% Stockholder | Form 144 notice | 755 | $1k | Notice | SEC | |
| Aug 17, 2023 | ALVR | Officer, Director, 10% owner | Form 4 sale | 10,516 | $26k | 0.9% | Unusual | SEC |
| Aug 17, 2023 | ALVR | Officer, Director, 10% Stockholder | Form 144 notice | 10,516 | $26k | Notice | SEC | |
| Jul 20, 2023 | ALVR | Officer, Director, 10% owner | Form 4 sale | 2,635 | $9k | 0.2% | Routine | SEC |
| Jul 20, 2023 | ALVR | Officer, Director, 10% Stockholder | Form 144 notice | 1,437 | $5k | Notice | SEC | |
| Jul 19, 2023 | ALVR | Officer, Director, 10% Stockholder | Form 144 notice | 1,198 | $4k | Notice | SEC | |
| Jul 5, 2023 | ALVR | Officer, Director, 10% owner | Form 4 sale | 2,983 | $9k | 0.3% | Routine | SEC |
| Jul 5, 2023 | ALVR | Officer, Director, 10% Stockholder | Form 144 notice | 2,983 | $9k | Notice | SEC | |
| Apr 20, 2023 | ALVR | Officer, Director, 10% owner | Form 4 sale | 2,683 | $10k | 0.2% | Routine | SEC |
| Apr 20, 2023 | ALVR | OFFICER, DIRECTOR, 10% STOCKHOLDER | Form 144 notice | 1,466 | $5k | Notice | SEC | |
| Apr 19, 2023 | ALVR | OFFICER, DIRECTOR, 10% STOCKHOLDER | Form 144 notice | 1,217 | $5k | Notice | SEC | |
| Jan 20, 2023 | ALVR | Officer, Director, 10% owner | Form 4 sale | 6,537 | $33k | 0.6% | Unusual | SEC |
| Oct 19, 2022 | ALVR | Officer, Director, 10% owner | Form 4 sale | 1,449 | $14k | 0.1% | Plan not stated | SEC |
| Jul 20, 2022 | ALVR | Officer, Director | Form 4 sale | 1,432 | $7k | 0.2% | Plan not stated | SEC |
| Apr 20, 2022 | ALVR | Officer, Director | Form 4 sale | 1,162 | $8k | 0.1% | Plan not stated | SEC |
| Jan 20, 2022 | ALVR | Officer, Director | Form 4 sale | 6,450 | $56k | 0.7% | Plan not stated | SEC |
| May 4, 2021 | VRNA | Director | Form 4 sale | 10,016 | $8k | 11.9% | Plan not stated | SEC |
| Feb 1, 2021 | VRNA | Director | Form 4 sale | 10,224 | $10k | 10.8% | Plan not stated | SEC |
| Aug 8, 2016 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 277 | $38k | 0.2% | Plan not stated | SEC |
| Feb 29, 2016 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 1,122 | $156k | 0.6% | Plan not stated | SEC |
| Feb 8, 2016 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 6,547 | $917k | 3.7% | Unusual | SEC |
| Aug 4, 2015 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 675 | $133k | 0.4% | Plan not stated | SEC |
| Mar 2, 2015 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 487 | $88k | 0.3% | Plan not stated | SEC |
| Feb 10, 2015 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 1,985 | $340k | 1.2% | Plan not stated | SEC |
| Feb 9, 2015 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 2,703 | $471k | 1.6% | Plan not stated | SEC |
| Feb 4, 2015 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 1,571 | $274k | 1.0% | Plan not stated | SEC |
| Dec 18, 2014 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 5,493 | $1M | 3.4% | Plan not stated | SEC |
| Dec 3, 2014 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 75,000 | $14.9M | 31.5% | Unusual | SEC |
| Nov 6, 2014 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 5,693 | $1.1M | 3.4% | Plan not stated | SEC |
| Nov 3, 2014 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 49,307 | $9.5M | 23.2% | Unusual | SEC |
| Aug 4, 2014 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 1,525 | $241k | 0.9% | Plan not stated | SEC |
| Feb 7, 2014 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 1,620 | $252k | 1.2% | Plan not stated | SEC |
| Feb 4, 2014 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 3,552 | $549k | 2.7% | Plan not stated | SEC |
| Jan 29, 2014 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 994 | $133k | 0.7% | Plan not stated | SEC |
| Dec 18, 2013 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 32,026 | $4.1M | 19.3% | Plan not stated | SEC |
| Dec 9, 2013 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 17,974 | $2.3M | 11.8% | Plan not stated | SEC |
| Oct 28, 2013 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 50,000 | $6.1M | 13.9% | Plan not stated | SEC |
| Aug 5, 2013 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 852 | $100k | 0.3% | Plan not stated | SEC |
| Jul 30, 2013 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 995 | $110k | 0.3% | Plan not stated | SEC |
| Jul 12, 2013 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 50,000 | $6M | 13.8% | Plan not stated | SEC |
| Feb 4, 2013 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 3,483 | $334k | 1.1% | Plan not stated | SEC |
| Jan 29, 2013 | ALEXION PHARMACEUTICALS INC | EVP & CFO | Form 4 sale | 1,982 | $187k | 0.6% | Plan not stated | SEC |
| Jul 31, 2012 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 31,768 | $3.5M | 9.2% | Plan not stated | SEC |
| Apr 26, 2012 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 48,000 | $4.3M | 13.2% | Unusual | SEC |
| Mar 20, 2012 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 21,996 | $2M | 5.7% | Plan not stated | SEC |
| Feb 14, 2012 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 40,000 | $3.4M | 9.9% | Plan not stated | SEC |
| Jan 30, 2012 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 4,343 | $324k | 1.2% | Plan not stated | SEC |
| Jan 10, 2012 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 21,036 | $1.6M | 5.6% | Plan not stated | SEC |
| Jul 27, 2011 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 26,305 | $1.5M | 7.0% | Unusual | SEC |
| Jul 13, 2011 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 14,566 | $765k | 4.0% | Unusual | SEC |
| Jul 11, 2011 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 977 | $49k | 0.3% | Plan not stated | SEC |
| Apr 1, 2011 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 10,000 | $1M | 10.4% | Unusual | SEC |
| Feb 14, 2011 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 20,000 | $1.8M | 18.8% | Unusual | SEC |
| Jan 27, 2011 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 1,731 | $147k | 2.3% | Plan not stated | SEC |
| Jan 18, 2011 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 540 | $45k | 0.7% | Plan not stated | SEC |
| Jan 10, 2011 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 532 | $43k | 0.7% | Plan not stated | SEC |
| Nov 19, 2010 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 20,000 | $1.5M | 21.4% | Unusual | SEC |
| Nov 3, 2010 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 20,000 | $1.4M | 22.4% | Unusual | SEC |
| Sep 28, 2010 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 20,000 | $1.3M | 23.5% | Unusual | SEC |
| Jul 16, 2010 | ALEXION PHARMACEUTICALS INC | CFO | Form 4 sale | 540 | $28k | 1.0% | Plan not stated | SEC |
| Jul 12, 2010 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 486 | $25k | 0.9% | Plan not stated | SEC |
| Mar 25, 2010 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 20,000 | $1.1M | 26.9% | Unusual | SEC |
| Feb 22, 2010 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 30,000 | $1.5M | 35.6% | Unusual | SEC |
| Jan 19, 2010 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 539 | $25k | 1.2% | Plan not stated | SEC |
| Jan 11, 2010 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 2,861 | $136k | 5.8% | Plan not stated | SEC |
| Dec 10, 2009 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 10,000 | $460k | 16.7% | Unusual | SEC |
| Sep 22, 2009 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 1,833 | $85k | 3.0% | Plan not stated | SEC |
| Jul 16, 2009 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 397 | $15k | 0.6% | Plan not stated | SEC |
| Jul 10, 2009 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 318 | $12k | 0.5% | Plan not stated | SEC |
| Mar 23, 2009 | ALEXION PHARMACEUTICALS INC | Sr. VP & CFO | Form 4 sale | 1,585 | $60k | 2.5% | Plan not stated | SEC |
| Mar 16, 2009 | ALEXION PHARMACEUTICALS INC | Sr. VP & CFO | Form 4 sale | 2,357 | $81k | 3.6% | Plan not stated | SEC |
| Jan 16, 2009 | ALEXION PHARMACEUTICALS INC | Sr. VP & CFO | Form 4 sale | 1,661 | $61k | 2.8% | Plan not stated | SEC |
| Jan 12, 2009 | ALEXION PHARMACEUTICALS INC | Sr. VP & CFO | Form 4 sale | 375 | $13k | 0.6% | Plan not stated | SEC |
| Sep 22, 2008 | ALEXION PHARMACEUTICALS INC | Sr. VP & CFO | Form 4 sale | 2,065 | $85k | 3.3% | Plan not stated | SEC |
| Aug 1, 2008 | ALEXION PHARMACEUTICALS INC | Sr VP and CFO | Form 4 sale | 10,000 | $924k | 24.3% | Unusual | SEC |
| Jul 10, 2008 | ALEXION PHARMACEUTICALS INC | SVP & CFO | Form 4 sale | 159 | $12k | 0.5% | Plan not stated | SEC |
| Mar 24, 2008 | ALEXION PHARMACEUTICALS INC | SVP & Chief Financial Officer | Form 4 sale | 1,025 | $60k | 3.2% | Plan not stated | SEC |
| Jan 10, 2008 | ALEXION PHARMACEUTICALS INC | SVP & Chief Financial Officer | Form 4 sale | 711 | $49k | 2.2% | Plan not stated | SEC |
| Sep 24, 2007 | ALEXION PHARMACEUTICALS INC | SVP & Chief Financial Officer | Form 4 sale | 4,162 | $263k | 12.7% | Plan not stated | SEC |